Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xilio Therapeutics Inc (NQ: XLO )

0.7790 -0.0033 (-0.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 504,184
Open 0.7862
Bid (Size) 0.7553 (2)
Ask (Size) 0.7999 (2)
Prev. Close 0.7823
Today's Range 0.7464 - 0.8200
52wk Range 0.4900 - 2.894
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Xilio Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
From Xilio Therapeutics, Inc.
Via GlobeNewswire
XLO Stock Earnings: Xilio Therapeutics Misses EPS for Q2 2024
XLO stock results show that Xilio Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
+35.48%
+35.48%
1 Month
-12.47%
-12.47%
3 Month
-14.24%
-14.24%
6 Month
+10.11%
+10.11%
1 Year
-66.71%
-66.71%

More News

Read More
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results
From Xilio Therapeutics, Inc.
Via GlobeNewswire
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
From Xilio Therapeutics, Inc.
Via GlobeNewswire
XLO Stock Earnings: Xilio Therapeutics Misses EPS for Q1 2024
Via InvestorPlace
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
From Xilio Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
XLO Stock Earnings: Xilio Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
From Xilio Therapeutics, Inc.
Via GlobeNewswire
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Cancer Focused Micro-Cap Xilio Therapeutics Stock Doubles In One Session - Here's Why
Via Benzinga
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Gold Gains 1%; Walgreens Narrows Earnings Forecast
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today?
Via InvestorPlace
Why Is Xilio Therapeutics (XLO) Stock up 168% Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.